163 related articles for article (PubMed ID: 16281441)
1. [Primary HIV infection: an update].
Schiffer V
Rev Med Suisse; 2005 Oct; 1(36):2310-4. PubMed ID: 16281441
[TBL] [Abstract][Full Text] [Related]
2. [Primary HIV infection].
Battegay M; Hirschel B
Ther Umsch; 2004 Oct; 61(10):609-12. PubMed ID: 15532189
[TBL] [Abstract][Full Text] [Related]
3. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and initial management of acute HIV infection.
Chu C; Selwyn PA
Am Fam Physician; 2010 May; 81(10):1239-44. PubMed ID: 20507048
[TBL] [Abstract][Full Text] [Related]
5. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection.
Chiappini E; Galli L; Tovo PA; Gabiano C; Gattinara GC; Guarino A; Badolato R; Giaquinto C; Lisi C; de Martino M;
AIDS; 2006 Jan; 20(2):207-15. PubMed ID: 16511413
[TBL] [Abstract][Full Text] [Related]
6. [HIV infections and children].
Baumann U
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():70-4. PubMed ID: 16385883
[TBL] [Abstract][Full Text] [Related]
7. How to recognize and treat acute HIV syndrome.
Perlmutter BL; Glaser JB; Oyugi SO
Am Fam Physician; 1999 Aug; 60(2):535-42, 545-6. PubMed ID: 10465228
[TBL] [Abstract][Full Text] [Related]
8. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
[TBL] [Abstract][Full Text] [Related]
10. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.
Warszawski J; Tubiana R; Le Chenadec J; Blanche S; Teglas JP; Dollfus C; Faye A; Burgard M; Rouzioux C; Mandelbrot L;
AIDS; 2008 Jan; 22(2):289-99. PubMed ID: 18097232
[TBL] [Abstract][Full Text] [Related]
11. Primary human immunodeficiency virus.
Taiwo BO; Hicks CB
South Med J; 2002 Nov; 95(11):1312-7. PubMed ID: 12539999
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
[TBL] [Abstract][Full Text] [Related]
14. Primary HIV type 1 infection.
Kassutto S; Rosenberg ES
Clin Infect Dis; 2004 May; 38(10):1447-53. PubMed ID: 15156484
[TBL] [Abstract][Full Text] [Related]
15. Short communication. Association of the CCR5delta32 mutation with clinical response and >5-year survival following initiation of first triple antiretroviral regimen.
Brumme ZL; Henrick BM; Brumme CJ; Hogg RS; Montaner JS; Harrigan PR
Antivir Ther; 2005; 10(7):849-53. PubMed ID: 16312181
[TBL] [Abstract][Full Text] [Related]
16. Predictors of short-term success of antiretroviral therapy in HIV infection.
Oette M; Kroidl A; Göbels K; Stabbert A; Menge M; Sagir A; Kuschak D; O'hanley T; Bode JG; Häussinger D
J Antimicrob Chemother; 2006 Jul; 58(1):147-53. PubMed ID: 16687458
[TBL] [Abstract][Full Text] [Related]
17. Intermittent antiretroviral therapy in patients with controlled HIV infection.
Marchou B; Tangre P; Charreau I; Izopet J; Girard PM; May T; Ragnaud JM; Aboulker JP; Molina JM;
AIDS; 2007 Feb; 21(4):457-66. PubMed ID: 17301564
[TBL] [Abstract][Full Text] [Related]
18. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
[TBL] [Abstract][Full Text] [Related]
19. Management of advanced HIV disease: resistance, antiretroviral brain penetration and malignancies.
Boffito M; Pillay D; Wilkins E
Int J Clin Pract; 2006 Sep; 60(9):1098-106. PubMed ID: 16939552
[TBL] [Abstract][Full Text] [Related]
20. Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection.
Hare CB; Pappalardo BL; Busch MP; Karlsson AC; Phelps BH; Alexander SS; Bentsen C; Ramstead CA; Nixon DF; Levy JA; Hecht FM
Clin Infect Dis; 2006 Mar; 42(5):700-8. PubMed ID: 16447118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
